# Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes

> **NCT02130401** · NA · TERMINATED · sponsor: **Scion NeuroStim** · enrollment: 6 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DEVICE:** TNM Device

## Key facts

- **NCT ID:** NCT02130401
- **Lead sponsor:** Scion NeuroStim
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-06
- **Primary completion:** 2015-05
- **Final completion:** 2015-06
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Poor enrollment (15 planned, only 6 enrolled)
- **Last updated:** 2025-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02130401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02130401, "Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02130401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*